Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Clinical trial NCT02837575 · COMPLETED

Trial details

NCT number

NCT02837575

Sponsor

Vical

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2016-09-01

Primary completion

2018-04-01

Enrollment

261

View on ClinicalTrials.gov